After Falling -13.95% During The Past Week, Should You Still Buy PDS Biotechnology Corporation (NASDAQ: PDSB)?
PDS Biotechnology Corporation (NASDAQ:PDSB)’s traded shares stood at 1.13 million during the last session, with the company’s beta value hitting 1.80. At the close of